6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide potassium salt cas no:55589-62-3
Synonyms: 1,2,3-Oxathiazin-4(3H)-one,6-methyl-, 2,2-dioxide, potassium salt (9CI);6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one2,2-dioxide potassium salt;Acesulfame K;Acesulfame potassium;E 950;Otizon;Potassium acesulfame;Sunett;Sunnett;Sweet One;Acesulfame K FCC4;1,2,3-Oxathiazin-4(3H)-one,6-methyl-, 2,2-dioxide, potassium salt (1:1);K Acesulfame;
Name6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide potassium salt
CAS55589-62-3
Synonyms1,2,3-Oxathiazin-4(3H)-one,6-methyl-, 2,2-dioxide, potassium salt (9CI);6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one2,2-dioxide potassium salt;Acesulfame K;Acesulfame potassium;E 950;Otizon;Potassium acesulfame;Sunett;Sunnett;Sweet One;Acesulfame K FCC4;1,2,3-Oxathiazin-4(3H)-one,6-methyl-, 2,2-dioxide, potassium salt (1:1);K Acesulfame;
EINECS(EC#)259-715-3
Molecular FormulaC4H5KNO4S
Molecular Weight201.24216
AppearanceWhite, odorless, free flowing crystalline powder
storage temp0-6°C
Risk R36/37/38
Safety
Risk Statements: 36/37/38?
R36/37/38: Irritating to eyes, respiratory system and skin
Safety Statements 26-36/37/39?
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection
WGK Germany: 1
RTECS: RP4489165
As?with aspartame,sucralose,saccharin, and other sweeteners that are sweeter than common sugars, there is concern over the safety of acesulfame potassium. Although studies of these sweeteners show varying and controversial degrees of dietary safety,USFDA (the United States Food and Drug Administration) has approved these for use as general-purpose sweetening agents. Critics of the use of acesulfame potassium say the chemical has not been studied adequately and may be carcinogenic, although these claims have been dismissed by the USFDA and by equivalent authorities in the European Union.
Based largely on animal studies,Several potential problems associated with the use of acesulfame have been raised:
1. been shown to stimulate insulin secretion in rats in a dose dependent fashion thereby possibly aggravating reactive hypoglycemia ("low blood sugar attacks").
2.?no increased incidence of tumors in response to administration of acesulfame K.
